glp-1 drugs pharmaceutical companies news 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP1 agonists set to become

Side effects vary by patient, dose, health history, and treatment plan

Treating Autoimmune Disease With Peptide Therapy If you suffer from an autoimmune disorder, you know that managing your symptoms can be a challenge

doi:10.3389/fphar.2025.1602018

The Unstoppable Rise of GLP-1 Agonists: Revolutionising Diabetes and Obesity Treatment Over the past two years, the pharmaceutical industry has witnessed an unprecedented surge in the development and deployment of GLP-1 receptor agonists

Surgeons, anesthesiologists, and primary care providers should collaborate to create a unified plan

With the rise of accessible telehealth services like Doctronic.ai, managing your health has never been easier or more convenient